Market Research Logo

Global insulin delivery device market Research Report, Insights, Opportunity Analysis, Market Shares and Forecast 2017 - 2023

Global insulin delivery device market Research Report, Insights, Opportunity Analysis, Market Shares and Forecast 2017 - 2023

The insulin delivery device market is growing with a CAGR of 9.1% over the forecast period 2016-2023. Insulin is the sugar regulating compound maintaining sugar level in the human body and insulin delivery device mainly used for the treatment of diabetes. Diabetic patients use insulin delivery device for injecting insulin dose. The key factors for the rise in the demand for the insulin delivery device market are increase in diabetic patient’s population, introduction of the new technologies in the insulin delivery devices, government support and reimbursement policies in selected countries and adoption of insulin delivery device due to awareness. Innovation in the pen needle market is playing important role in boosting the insulin delivery device market. Pen needle market comes with the techniques which reduce the pain and decrease the needle stick wounds. The global pen needle market is expected to grow with during forecasted period and shared $1.5 billion of market size in 2015.

Global insulin delivery device market is bifurcated into type based and end-user based segments. Based on type, the market is sub-divided into pen needles, pens, pumps, insulin syringes and other devices. The insulin pens segment is further divided into reusable pens and disposable pens. The pumps segment is further segmented as patch pumps and external/tethered pumps. The pen needles market is sub divided into safety pen needles and standard pen needles. On the basis end-user, the insulin delivery device market is segmented into hospitals & clinics and patients/homecare.

Geographically the global insulin delivery device market is segmented as North America, Europe, Asia and rest of the world. North America is the dominating insulin delivery device market, followed by Europe and Asia. North America shares largest market size of insulin delivery device market in 2016 due to favorable reimbursement by government in the U.S. However, Europe will hold a small market share and Asia is expected to have the highest growth during forecasted period. The Asian market is also increasing in the insulin delivery device market due to growing geriatric population. The key players in the global insulin delivery device market are Becton, Dickinson and Company, Novo Nordisk A/S, Ypsomed Holding AG, Owen Mumford, Ltd and others.

Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.


1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY
2. MARKET OVERVIEW
2.1. GLOBAL INSULIN DELIVERY DEVICE MARKET: EVOLUTION & TRANSITION
2.2. MARKET DEFINITION & SCOPE
2.3. INDUSTRY STRUCTURE
2.4. REGULATORY FRAMEWORK
2.5. TOTAL MARKET ANALYSIS
2.5.1. TOP 5 FINDINGS
2.5.2. TOP 5 OPPORTUNITY MARKETS
2.5.3. TOP 5 COMPANIES
2.5.4. TOP 3 COMPETITIVE STRATEGIES
2.6. ESTIMATION ANALYSIS
2.7. STRATEGIC ANALYSIS
2.7.1. INVESTMENT VS. ADOPTION MODEL
2.7.2. 360 DEGREE INDUSTRY ANALYSIS
2.7.3. PORTERS 5 FORCE MODEL
2.7.4. SEE-SAW ANALYSIS
2.7.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.8. COMPETITIVE ANALYSIS
2.8.1. KEY STRATEGIES & ANALYSIS
2.8.2. MARKET SHARE ANALYSIS & TOP COMPANY ANALYSIS
2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
3. MARKET DETERMINANTS
3.1. MARKET DRIVERS
3.1.1. GROWING DIABETIC POPULATION
3.1.2. TECHNOLOGICAL ADVANCEMENTS
3.1.3. FAVORABLE REIMBURSEMENT POLICIES IN SELECTED COUNTRIES
3.1.4. INCREASING AWARENESS PROGRAMS
3.2. MARKET RESTRAINTS
3.2.1. POOR REIMBURSEMENT STRUCTURE
3.2.2. ISSUES ASSOCIATED WITH THE REUSE OF PEN NEEDLES AND INFUSION SETS
3.3. MARKET OPPORTUNITIES
3.3.1. INCREASING RESEARCH AND DEVELOPMENT ACTIVITIES
3.3.2. INCREASING EXPENDITURE IN DIABETES CARE
3.3.3. SAFETY NEEDLES
3.4. MARKET CHALLENGES
3.4.1. SEVERE SHORTAGE OF ENDOCRINOLOGISTS IN THE U.S
4. MARKET SEGMENTATION
4.1. GLOBAL INSULIN DELIVERY DEVICE MARKET BY TYPE
4.1.1. MARKET DEFINITION AND SCOPE
4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.1.4. OPPORTUNITY MATRIX
4.1.5. MARKET SEGMENTATION
4.1.5.1. GLOBAL PENS MARKET
4.1.5.1.1. APPLICATION
4.1.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.1.4. KEY PLAYERS & KEY PRODUCTS
4.1.5.1.5. KEY CONCLUSIONS
4.1.5.2. GLOBAL INSULIN PUMPS MARKET
4.1.5.2.1. APPLICATION
4.1.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.2.4. KEY PLAYERS & KEY PRODUCTS
4.1.5.2.5. KEY CONCLUSIONS
4.1.5.3. GLOBAL PEN NEEDLES MARKET
4.1.5.3.1. APPLICATION
4.1.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.3.4. KEY PLAYERS & KEY PRODUCTS
4.1.5.3.5. KEY CONCLUSIONS
4.1.5.4. GLOBAL INSULIN SYRINGES MARKET
4.1.5.4.1. APPLICATION
4.1.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.4.4. KEY PLAYERS & KEY PRODUCTS
4.1.5.4.5. KEY CONCLUSIONS
4.1.5.5. GLOBAL OTHERS MARKET
4.1.5.5.1. APPLICATION
4.1.5.5.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.5.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.5.4. KEY PLAYERS & KEY PRODUCTS
4.1.5.5.5. KEY CONCLUSIONS
4.2. GLOBAL INSULIN DELIVERY DEVICE MARKET BY END-USER
4.2.1. MARKET DEFINITION AND SCOPE
4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.2.4. OPPORTUNITY MATRIX
4.2.5. MARKET SEGMENTATION
4.2.5.1. GLOBAL PATIENTS/HOMECARE MARKET
4.2.5.1.1. APPLICATION
4.2.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.1.4. KEY PLAYERS & KEY PRODUCTS
4.2.5.1.5. KEY CONCLUSIONS
4.2.5.2. GLOBAL HOSPITALS & CLINICS MARKET
4.2.5.2.1. APPLICATION
4.2.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.2.4. KEY PLAYERS & KEY PRODUCTS
4.2.5.2.5. KEY CONCLUSIONS
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.1.1. LIST OF MERGERS AND ACQUISITIONS
5.1.2. LIST OF JOINT VENTURES
5.1.3. LIST OF PRODUCT LAUNCHES
5.1.4. LIST OF PARTNERSHIPS
6. GEOGRAPHIC ANALYSIS
6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
6.3. OPPORTUNITY MATRIX
7. GLOBAL INSULIN DELIVERY DEVICE MARKET BY REGION 2014-2023 ($ MILLION)
7.1.1. NORTH AMERICA
7.1.1.1. INDUSTRY APPLICATION ANALYSIS
7.1.1.2. TOP COUNTRY ANALYSIS
7.1.1.2.1. U.S.
7.1.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
7.1.1.2.1.2. KEY PLAYERS & KEY PRODUCTS
7.1.1.2.1.3. KEY CONCLUSIONS
7.1.1.2.2. CANADA
7.1.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
7.1.1.2.2.2. KEY PLAYERS & KEY PRODUCTS
7.1.1.2.2.3. KEY CONCLUSIONS
7.1.2. EUROPE
7.1.2.1. INDUSTRY APPLICATION ANALYSIS
7.1.2.2. TOP COUNTRY ANALYSIS
7.1.2.2.1. UK
7.1.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
7.1.2.2.1.2. KEY PLAYERS & KEY PRODUCTS
7.1.2.2.1.3. KEY CONCLUSIONS
7.1.2.2.2. FRANCE
7.1.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
7.1.2.2.2.2. KEY PLAYERS & KEY PRODUCTS
7.1.2.2.2.3. KEY CONCLUSIONS
7.1.2.2.3. GERMANY
7.1.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
7.1.2.2.3.2. KEY PLAYERS & KEY PRODUCTS
7.1.2.2.3.3. KEY CONCLUSIONS
7.1.2.2.4. SPAIN
7.1.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
7.1.2.2.4.2. KEY PLAYERS & KEY PRODUCTS
7.1.2.2.4.3. KEY CONCLUSIONS
7.1.2.2.5. REST OF EUROPE
7.1.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
7.1.2.2.5.2. KEY PLAYERS & KEY PRODUCTS
7.1.2.2.5.3. KEY CONCLUSIONS
7.1.3. ASIA PACIFIC
7.1.3.1. INDUSTRY APPLICATION ANALYSIS
7.1.3.2. TOP COUNTRY ANALYSIS
7.1.3.2.1. CHINA
7.1.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
7.1.3.2.1.2. KEY PLAYERS & KEY PRODUCTS
7.1.3.2.1.3. KEY CONCLUSIONS
7.1.3.2.2. INDIA
7.1.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
7.1.3.2.2.2. KEY PLAYERS & KEY PRODUCTS
7.1.3.2.2.3. KEY CONCLUSIONS
7.1.3.2.3. JAPAN
7.1.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
7.1.3.2.3.2. KEY PLAYERS & KEY PRODUCTS
7.1.3.2.3.3. KEY CONCLUSIONS
7.1.3.2.4. AUSTRALIA
7.1.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
7.1.3.2.4.2. KEY PLAYERS & KEY PRODUCTS
7.1.3.2.4.3. KEY CONCLUSIONS
7.1.3.2.5. REST OF ASIA PACIFIC
7.1.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
7.1.3.2.5.2. KEY PLAYERS & KEY PRODUCTS
7.1.3.2.5.3. KEY CONCLUSIONS
7.1.4. ROW
7.1.4.1. INDUSTRY APPLICATION ANALYSIS
7.1.4.2. TOP COUNTRY ANALYSIS
7.1.4.2.1. LATIN AMERICA
7.1.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
7.1.4.2.1.2. KEY PLAYERS & KEY PRODUCTS
7.1.4.2.1.3. KEY CONCLUSIONS
7.1.4.2.2. MIDDLE EAST & AFRICA
7.1.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
7.1.4.2.2.2. KEY PLAYERS & KEY PRODUCTS
7.1.4.2.2.3. KEY CONCLUSIONS
8. COMPANY PROFILES
8.1. ALLISON MEDICAL INC. (U.S.)
8.1.1. OVERVIEW
8.1.2. PRODUCT PORTFOLIO
8.1.3. STRATEGIC INITIATIVES
8.1.4. SCOT ANALYSIS
8.1.5. STRATEGIC ANALYSIS
8.2. BAXTER INTERNATIONAL INC. (U.S.)
8.2.1. OVERVIEW
8.2.2. PRODUCT PORTFOLIO
8.2.3. STRATEGIC INITIATIVES
8.2.4. SCOT ANALYSIS
8.2.5. STRATEGIC ANALYSIS
8.3. BECTON, DICKINSON AND COMPANY (U.S.)
8.3.1. OVERVIEW
8.3.2. PRODUCT PORTFOLIO
8.3.3. STRATEGIC INITIATIVES
8.3.4. SCOT ANALYSIS
8.3.5. STRATEGIC ANALYSIS
8.4. B. BRAUN MELSUNGEN (GERMANY)
8.4.1. OVERVIEW
8.4.2. PRODUCT PORTFOLIO
8.4.3. STRATEGIC INITIATIVES
8.4.4. SCOT ANALYSIS
8.4.5. STRATEGIC ANALYSIS
8.5. COVIDIEN PLC (IRELAND)
8.5.1. OVERVIEW
8.5.2. PRODUCT PORTFOLIO
8.5.3. STRATEGIC INITIATIVES
8.5.4. SCOT ANALYSIS
8.6. FRESENIUS MEDICAL CARE AG & CO. KGAA (GERMANY)
8.6.1. OVERVIEW
8.6.2. PRODUCT PORTFOLIO
8.6.3. STRATEGIC INITIATIVES
8.6.4. SCOT ANALYSIS
8.6.5. STRATEGIC ANALYSIS
8.7. HTL STREFA S.A. (POLAND)
8.7.1. OVERVIEW
8.7.2. PRODUCT PORTFOLIO
8.7.3. STRATEGIC INITIATIVES
8.7.4. SCOT ANALYSIS
8.7.5. STRATEGIC ANALYSIS
8.8. KONINKLIJKE PHILIPS ELECTRONICS NV. (NETHERLANDS)
8.8.1. OVERVIEW
8.8.2. PRODUCT PORTFOLIO
8.8.3. STRATEGIC INITIATIVES
8.8.4. SCOT ANALYSIS
8.8.5. STRATEGIC ANALYSIS
8.9. MEDTRONIC INC. (U.S.)
8.9.1. OVERVIEW
8.9.2. PRODUCT PORTFOLIO
8.9.3. STRATEGIC INITIATIVES
8.9.4. SCOT ANALYSIS
8.9.5. STRATEGIC ANALYSIS
8.10. NOVO NORDISK A/S (DENMARK)
8.10.1. OVERVIEW
8.10.2. PRODUCT PORTFOLIO
8.10.3. STRATEGIC INITIATIVES
8.10.4. SCOT ANALYSIS
8.10.5. STRATEGIC ANALYSIS
8.11. OWEN MUMFORD, LTD. (U.K.)
8.11.1. OVERVIEW
8.11.2. PRODUCT PORTFOLIO
8.11.3. STRATEGIC INITIATIVES
8.11.4. SCOT ANALYSIS
8.11.5. STRATEGIC ANALYSIS
8.12. SANOFI (FRANCE)
8.12.1. OVERVIEW
8.12.2. PRODUCT PORTFOLIO
8.12.3. STRATEGIC INITIATIVES
8.12.4. SCOT ANALYSIS
8.12.5. STRATEGIC ANALYSIS
8.13. TERUMO CORPORATION (JAPAN)
8.13.1. OVERVIEW
8.13.2. PRODUCT PORTFOLIO
8.13.3. STRATEGIC INITIATIVES
8.13.4. SCOT ANALYSIS
8.13.5. STRATEGIC ANALYSIS
8.14. ULTIMED, INC. (U.S.)
8.14.1. OVERVIEW
8.14.2. PRODUCT PORTFOLIO
8.14.3. STRATEGIC INITIATIVES
8.14.4. SCOT ANALYSIS
8.14.5. STRATEGIC ANALYSIS
8.15. YPSOMED HOLDING AG (SWITZERLAND)
8.15.1. OVERVIEW
8.15.2. PRODUCT PORTFOLIO
8.15.3. STRATEGIC INITIATIVES
8.15.4. SCOT ANALYSIS
8.15.5. STRATEGIC ANALYSIS
LIST OF TABLES
GLOBAL INSULIN DELIVERY DEVICE MARKET BY TYPE 2014-2023 ($ MILLION)
GLOBAL PENS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL INSULIN PUMPS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL PEN NEEDLES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL INSULIN SYRINGES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL OTHERS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL INSULIN DELIVERY DEVICE MARKET BY END-USER 2014-2023 ($ MILLION)
GLOBAL PATIENTS/HOMECARE MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL HOSPITALS & CLINICS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
NORTH AMERICA INSULIN DELIVERY DEVICE MARKET 2014-2023 ($ MILLION)
EUROPE INSULIN DELIVERY DEVICE MARKET 2014-2023 ($ MILLION)
ASIA PACIFIC INSULIN DELIVERY DEVICE MARKET 2014-2023 ($ MILLION)
REST OF THE WORLD INSULIN DELIVERY DEVICE MARKET 2014-2023 ($ MILLION)
LIST OF FIGURES
GLOBAL PENS MARKET 2014-2023 ($ MILLION)
GLOBAL INSULIN PUMPS MARKET 2014-2023 ($ MILLION)
GLOBAL PEN NEEDLES MARKET 2014-2023 ($ MILLION)
GLOBAL INSULIN SYRINGES MARKET 2014-2023 ($ MILLION)
GLOBAL OTHERS MARKET 2014-2023 ($ MILLION)
GLOBAL PATIENTS/HOMECARE MARKET 2014-2023 ($ MILLION)
GLOBAL HOSPITALS & CLINICS MARKET 2014-2023 ($ MILLION)
UNITED STATES (U.S.) INSULIN DELIVERY DEVICE MARKET 2014-2023 ($ MILLION)
CANADA INSULIN DELIVERY DEVICE MARKET 2014-2023 ($ MILLION)
UNITED KINGDOM (UK) INSULIN DELIVERY DEVICE MARKET 2014-2023 ($ MILLION)
FRANCE INSULIN DELIVERY DEVICE MARKET 2014-2023 ($ MILLION)
GERMANY INSULIN DELIVERY DEVICE MARKET 2014-2023 ($ MILLION)
SPAIN INSULIN DELIVERY DEVICE MARKET 2014-2023 ($ MILLION)
ROE INSULIN DELIVERY DEVICE MARKET 2014-2023 ($ MILLION)
INDIA INSULIN DELIVERY DEVICE MARKET 2014-2023 ($ MILLION)
CHINA INSULIN DELIVERY DEVICE MARKET 2014-2023 ($ MILLION)
JAPAN INSULIN DELIVERY DEVICE MARKET 2014-2023 ($ MILLION)
AUSTRALIA INSULIN DELIVERY DEVICE MARKET 2014-2023 ($ MILLION)
ROAPAC INSULIN DELIVERY DEVICE MARKET 2014-2023 ($ MILLION)
LATIN AMERICA INSULIN DELIVERY DEVICE MARKET 2014-2023 ($ MILLION)
MENA INSULIN DELIVERY DEVICE MARKET 2014-2023 ($ MILLION)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report